It has been speculated that the mutation of tumor suppressor NF-1 gene increases the patient's risk for the development of various malignancies mainly derived from the neural crest such as malignant schwannoma, neurofibrosarcoma, intracranial glioma, and pheochromocytoma. This evidence concerns the gene NF1 and neurofibrosarcoma.